All news from Anaesthesiology

Anti-inflammatory Drug Reduces Cardiovascular Risks in a Subset of Population

A new study published in the Journal of the American College of Cardiology (JACC) found that anti-inflammatory therapy canakinumab substantially reduced cardiovascular event rates in high-risk atherosclerotic patients with chronic kidney disease (CKD) or those with pre-diabetes/diagnosed type 2 diabetes, while having neither clinically meaningful benefits nor substantive harms with respect to adverse renal events or glucose control.


Researchers Find Key Step in Viral Replication

A new study, published in the journal Nature Microbiology, provide insight into how a common virus hijacks a host cell's protein to help assemble new viruses before they are released. The results increase our understanding of how viruses reproduce in the body and establish a rationale for the development of protein inhibitor as potential antiviral therapeutics.

New Protein Structure Related To Neurodegenerative Disorders

In this study, researchers have determined the structure of a key protein that is involved in the body's inflammatory response. This finding opens the door to developing new treatments for a wide range of illnesses, from heart disease, diabetes, and cancer to neurodegenerative disorders, including Parkinson's disease. The studies on protein structures at the atomic resolution level to understand the mechanism of their function in the body.

For-Profit System Drives High US Health Costs

A new study published in JAMA shows that high healthcare spending in the U.S. stems not just from elevated prescription drug costs or its fee-for-service model—but from high costs across the American healthcare industry. The United States spends nearly double what 10 other wealthy nations spend on healthcare, researchers report.